A vitamin found in sunlight and fish oil is now at the center of serious psoriasis research, with scientists reporting measurable improvement in skin severity scores among patients who took it alongside standard treatment.
Story Snapshot
- A 2025 review of 21 clinical trials and 1,463 psoriasis patients tested eight different supplements as add-on treatments.
- Vitamin D showed a meaningful drop in psoriasis severity scores in that analysis, though other studies found no benefit at all.
- Omega-3 fish oil has one of the largest supplement evidence bases for psoriasis, with mixed but notable results.
- No major dermatology group currently recommends supplements as a routine psoriasis treatment, citing inconsistent study designs.
What The New Research Actually Found
Psoriasis affects millions of Americans with thick, scaly, often painful skin patches. For years, doctors leaned almost entirely on topical creams, light therapy, and immune-suppressing drugs. Now a growing body of clinical research is asking a different question: can everyday nutritional supplements meaningfully calm the disease from the inside out, working alongside those existing treatments rather than replacing them.
The strongest signal comes from a 2025 network meta-analysis covering 21 randomized controlled trials and 1,463 plaque psoriasis patients. Researchers measured results using the Psoriasis Area and Severity Index, the standard scale doctors use to grade how much skin is affected and how bad it looks. Vitamin D supplementation stood out, showing a meaningful reduction in that severity score when added to standard care.
Vitamin D And Fish Oil Lead, But Evidence Splits
That finding sits next to a harder truth: not every study agrees. A separate systematic review and meta-analysis found vitamin D produced no significant improvement over a placebo at all, with results essentially flat. Researchers describe oral vitamin D as not yet ready for a blanket recommendation because high-quality, consistent proof is still missing. Two credible reviews, two different conclusions, same vitamin.
Omega-3 fatty acids from fish oil tell a similar story. A 2019 meta-analysis of 10 trials and 560 participants linked omega-3 supplementation to a drop in severity scores. A separate historical review found 15 fish-oil trials, with 12 showing some clinical benefit and three showing none, across patients who varied widely in age, disease severity, and dosage. Fish oil looks promising, but it is far from proven as a standalone fix.
Probiotics And Curcumin Join The Watch List
Beyond vitamin D and fish oil, researchers are tracking probiotics, curcumin, and other micronutrients. A 2026 narrative review described encouraging trends for all three, while bluntly noting the studies behind them are too small and too different from each other to draw firm conclusions. The idea that gut health connects to skin inflammation is gaining traction in labs, even if it has not yet translated into a standardized treatment anyone can prescribe with confidence.
Common Nutritional Supplement May Treat Psoriasishttps://t.co/INTWD00TWu
— Mirage News (@MirageNewsCom) October 27, 2026
What Comes Next For Patients And Researchers
Scientists now say the obvious next step is a properly designed trial that tests personalized supplement combinations against a placebo, tracking the same patients over six to twelve months with standardized severity scoring. Researchers also want to test whether patients with an actual vitamin D or omega-3 deficiency respond differently than those who already have normal levels, since baseline nutrition might explain why past studies clashed so often.
For now, patients weighing supplements should treat them as a possible complement to proven treatment, not a replacement for it. The evidence is real, the interest from researchers is real, and the severity-score improvements in several trials are real. What is still missing is the kind of large, consistent, head-to-head study that turns a promising lab signal into a standard doctor’s recommendation. That work is reportedly already underway.
Sources:
youtube.com, pmc.ncbi.nlm.nih.gov, tandfonline.com, cambridge.org
